A Fortune 100 health care company has established a presence in St. Louis looking to help the city’s growing number of health care startups navigate the maze of regulations that await their products and drugs.
Ohio-based Cardinal Health, which specializes in the distribution of pharmaceuticals and medical products, established a regulatory office in St. Louis — just its third such office in the U.S.
The office helps address a growing need in the market, local health care experts say.
Sean Morris, CEO of St. Louis-based Pulse Therapeutics, said the regulatory component is one of the obstacles that hinders the development of health care startups. He said he’s surprised Cardinal is opening its office in St. Louis, rather than traditional drug and medical device development hubs like Boston or Minneapolis.